WO1986000234A1 - Process and apparatus for diaphragmic stimulation - Google Patents

Process and apparatus for diaphragmic stimulation Download PDF

Info

Publication number
WO1986000234A1
WO1986000234A1 PCT/US1985/001156 US8501156W WO8600234A1 WO 1986000234 A1 WO1986000234 A1 WO 1986000234A1 US 8501156 W US8501156 W US 8501156W WO 8600234 A1 WO8600234 A1 WO 8600234A1
Authority
WO
WIPO (PCT)
Prior art keywords
diaphragm
electrodes
stimulation
respiration
sensor
Prior art date
Application number
PCT/US1985/001156
Other languages
French (fr)
Inventor
Jacques Mugica
Original Assignee
Medtronic, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic, Inc. filed Critical Medtronic, Inc.
Priority to DE8585903508T priority Critical patent/DE3581284D1/en
Publication of WO1986000234A1 publication Critical patent/WO1986000234A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3601Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of respiratory organs

Definitions

  • the instant invention relates to the stimulation of human body organs and relates more particularly to diaphragmic stimulation to effect respiration.
  • patients who undergo thoracic surqery may, for a varying period following the surgical procedure, suffer a temporary paralysis of their respiratory system.
  • Such patients require ventilatory support during the post-operative recovery period.
  • That support which involves inducing artificial respiration, is typically effected by a mechanical respirator which applies a cyclic pressure to the pulmonary cavities. This is done directly by forcing air or oxygen into the lungs via the nasopharynx and the trachea, or indirectly by enclosing either the chest or the entire body with the exception of the head and neck and cyclicly pressurizing the enclosure so that the resulting chest movements stimulates natural breathing.
  • the invention has as its object a process for diaphragmic stimulation adapted to assist respiratory movements of a patient characterized in that it consists in implanting, in the muscular tissues of at lest one-half portion of the diaphragm, stimulation electrodes distributed about the periphery of said half portion and in applying to each electrode a pulse train in which the amplitude, width and frequency of each pulse is variable in accordance with a predetermined program to provide each electrode with energy which is apropriate for the corresponding zone of the diaphragm.
  • a number of leads e.g. 6 active and up to 6 passive leads, each with one or more electrodes, may be passed through and along the diaphragm muscle to provide many points of stimulation. Stimuli may be applied sequentially to each active lead to provide rhythmic contraction of the diaphragm.
  • the time spacing between pulse trains as sequentially applied to the different electrodes, as well as the frequency or repetition sequence of the pulse trains, are variable in accordance with a predetermined program.
  • This repetition sequence is determined for each patient by testing the reactions of the patient to various stimulations. Once the best combination of values is determined, this combination is stored in a memory, and stimulation will then take place in accordance with these stored values.
  • An important advantage of the instant invention in regard to prior art respiration devices is as follows: in convention artificial respiration devices, air is brought into the lungs of the patient by pushing the diaphragm in a downward direction. This causes a problem as the externally directed force in the lungs of the patient also causes pressure to be applied against the auricle of the heart and thus interferes with blood circulation which in turn, retards the patient's rate of recovery.
  • the diaphragm is displaced by electric means for the purpose of bringing air into the lungs. As there is no artificial forcing of air into the lungs, there is no pressure exerted against the heart and no obstacle to blood circulation.
  • this procedure avoids exposure of the phrenic nerve in the region of the neck and advantageously can be conducted following other chest surgery.
  • the transcutaneous leads can be withdrawn by traction similar to the manner in which a temporary heart pacing wire is retracted.
  • Fig. 1 is a schematic of the upper portion of the diaphragm in which are implanted stimulation electrodes according to the invention
  • Fig. 2 is a schematic view of a bipolar electrode system implanted in the diaphragm muscle
  • Fig. 3 is a schematic of a device for diaphragmic stimulation according to the invention.
  • Fig. 4 is a diagram showing a one type of pulse which can be used for diaphragmic stimulation
  • Fig. 5 is another type of pulse which can be used for diaphragmic stimulation
  • Figs. 6 and 7 show two recordings of stimulation pulse trains
  • Fig. 8 shows examples of envelopes of stimulation signals
  • Fig. 9 shows a simplified flowchart of the method of triggering the delivery of stimulating pulses in the absence of spontaneous respiration
  • Fig. 10 illustrates how pulse trains are sequentially applied to the six outputs of the device shown in Fig. 3 to effect a rhythmic contraction of the diaphragm;
  • Fig. 11 shows a preferred unipolar, multi-electrode lead for implantation in the diaphragm for temporary stimulation
  • Fig. 12 shows a cross-section view of a portion of the lead of Fig. 11.
  • Fig. 1 there is shown schematically the muscle of diaphragm 1 with unipolar or bipolar electrodes 2 implanted in the muscle tissue at the external periphery of half of the diaphragm.
  • electrodes 2 implanted in the muscle tissue at the external periphery of half of the diaphragm.
  • sub-portions of these electrodes can be distributed along several lead wires, each having a common conductor.
  • the inventor has noted that the quality of contraction depends upon the emplacement selected for the electrodes in the diaphragm as well as the form of the stimulation pulse trains. It has been noted that the implantation of stimulation electrodes in only a single half of the diaphragm yields good results, and this also limits the amount of surgical intervention, which is in any case- quite substantial.
  • a diaphragm movement sensor 4 is placed in the other half of the diaphragm 5. This is so it often occurs that one side of the diaphragm functions normally with the other half being incapacitated and requiring stimulation. In such cases, the sensor 4 detects the normal movement of the diaphragm and emits signals which are utilized (in the system of Fig. 3) to trigger the stimulation of the other half of the diaphragm. through electrodes contacting it so as to obtain a natural rhythmn.
  • the sensor 4 can be, for example, a pressure sensor, an impedance sensor, an EEG sensor or an activity sensor, and more than one can be provided. The activiation of the stimulating electrodes will therefore be dependent upon the mechanical or electrical activity in the diaphragm portion 5 detected by sensor 4. Of course, sensors and electrodes may be placed on or in both portions 3 and 5 of the diaphragm.
  • a suitable blood gas sensor e.g., a sensor for pH, p02 or pC02 could be employed in the bloodstream to provide a control signal when oxygen tension falls below a preset limit to trigger operation of the respiration device of Fig. 3.
  • Fig. 2 shows schematically a bipolar single electrode lead of the type used in the invention.
  • This lead is derived from the Medtronic temporary pacing lead model 6400 which is a temporary myocardial heart wire used for cardiac stimulation.
  • the lead consists of two electrodes 6 and 7 which receive positive and negative stimulation signals, or act as the active and passive stimulating electrodes.
  • the bipolar lead includes ring electrodes 6 and 7 of biocompatible metal, such as for example, platinum, nonconductive filaments 14, each having a winding or coil 9 for fixing the electrodes into muscle 10, and lead bodies 11 extending to connector 12 for attachment to an excitation signal generator which will be discussed in connection with Fig. 3.
  • Each lead body and electrode is drawn into the muscle 10 by perforating the muscle with its respective needle 13 and drawing the filament 14 and coil 9 into the muscle.
  • the filament 14 is severed leaving the coil 9 in place to retain the electrode 6 or 7 in place.
  • Other types of leads for example, one or more unipolar leads having several electrodes of the type shown in Figs. 11 and 12 can also be used.
  • the electrodes can be implanted by open thoracic or open abdomenal surgical intervention. Implantation can also be effected by endoscopy, by pleuroscopy or peritonioscopy. The lead may later be retracted to pull the electrodes and coils out of the diaphragm and out of the patient's body through the skin incision.
  • Fig. 1 represents the electrodes which are implanted in the diaphram; however, these electrodes might also be affixed to a net or a plastic film element or similar, and this net or plastic film element might then be affixed to the diaphragm, the electrodes being placed in physical contact with the upper or lower portions of the diaphragm. In this manner, electric energy can be delivered to the diaphragm without a physical implantation of the electrodes within the diaphragmatic muscle. However, such an arrangement would not be retractable through the skin in the fashion that the temporary lead wire described herein may be used.
  • Fig. 3 shows the overall arrangement of the diaphragmatic stimulation device according to the invention.
  • the stimulation apparatus shown in this figure includes a user interface 15 to which are connected a keyboard 16 and a printer 17.
  • the interface 15 can be a micro-computer ELTEC system 7000 with a 6809 processor, a 64K memory and two 320K disc readers which effect the following functions:
  • Modification of stimulation parameters such as pulse amplitude, frequency and width and the envelope of the stimulation signals as well as the time interval between different pulse trains as well as the electrode choice;
  • Data control storing of the stimulation program, control of the printer, programming the stimulator.
  • the interface 15 is connected to a stimulator 18 through several, e.g. six, for example, independent floating unipolar or bipolar capacitive coupling outputs of the constant current or constant voltage type (or any other source of energy) connected to electrodes such as electrodes 2 of Fig. 1 implanted in patient P.
  • the stimulator 18 includes a permanent stimulation path 19, a temporary stimulation path 20 and an emergency stimulation path 21; these three paths are connected to interface 15 by means of a commutator 22 and are connected to patient P by means of cable 23 and commutator 24. These commutators provide for stimulation independent of the interface 15 after programming.
  • the stimulator 18 includes in addition an input 25 for remote control.
  • the control signal from the sensor 4 of Fig. 1 or other sensors as described above may be applied to the interface 15 which responds through suitable software to interrupt the delivery of stimulating or excitation pulse trains when the patient experiences spontaneous respiration or the blood gas levels are within normal ranqe.
  • the control signal from sensor 4 is delivered in time sequence from patient P to interface 15 via cable 23 and stimulator 18.
  • the signal from sensor 4 may instead be separately input directly into interface 15.
  • signals developed by blood gas sensors or internal impedance plethysomograph signals may be developed from electrodes spaced apart on the diaphragm or in the chest cavity may be applied to interface 15.
  • an external thoracic belt with spaced electrodes can be used temporarily to develop an impedance plethysmograph control signal directly inputted into interface 15.
  • Fig. 9 illustrates how the sensor output is utilized to provide "inhibit” or “stimulate” control signals through commutator 22 to stimulator 18.
  • the sensor develops an electrical signal representative of diaphragmic contraction, the signal having an amplitude representative of the strength of contraction. The interval between successive contractions is inverted to provide a contraction rate.
  • the sensor output (rate and amplitude) is first compared to a minimum rate; if the rate is below the minimum, a "stimulate" command is given to pulse generator 18. If the rate is above the minimum, then the amplitude is compared to a minimum amplitude. If the amplitude is below the minimum, then a "stimulate” command is given even though the rate, or interval between successive respirations, is acceptable. If the amplitude is above the minimum, then the "inhibit" command is given to the pulse generator 18. Thus, to inhibit, both rate and amplitude must be within normal ranges; to stimulate either rate or amplitude need be below normal.
  • the control means for stimulation are external to the body
  • the stimulator can also be implanted in the body and programmed from the exterior.
  • Such implanted stimulators utilizing external programming means are widely used today in cardiac stimulation, with the program stored in the implanted stimulator being controlled and modified remotely from outside of the body by electromagnetic means, for example.
  • the phenomena of muscular fatigue causes a reduction in the contraction response to an electric stimulation occasioned by irrevesible electro-chemical reactions at the muscle nerve electrode interface.
  • the electric pulses must satisfy the following conditions:
  • the intensity of the current during the time of the positive and negative pulse phases must be the same.
  • a pulse which would satisfy the first condition is seen in Fig. 4 in which the area of the positive rectangular pulses 30 and the area of the negative triangular pulses 31 are equal.
  • the second condition would be satisfied by the pulses shown in Fig. 5.
  • a pulse which satisfies both conditions will provide better resistance to fatigue than a pulse which satisfies only the first condition.
  • a train of pulses can be characterized by three parameters: the envelope of the amplitude of the pulses; the envelope of the width of the pulses; the envelope the frequency of the pulses.
  • These three envelopes can include an increasing phase, a constant phase and a decreasing phase which can be linear or curved.
  • One can vary the form of the envelopes and adjust them in a way to obtain the desired contraction of the diaphragm muscles.
  • Figs. 6 and 7 there are shown two representations of actual recordings of pulse trains.
  • Fig. 6 shows a monophase train of pulses having a linear amplitude envelope and a constant envelope as to pulse width and frequency.
  • Fig. 7 shows a biphasic train of pulses having a curved amplitude envelope, a curved frequency envelope and a constant pulse width envelope.
  • the table which follows show, as an example, the most significant parameters and their particular range adapted to this particular - . __-
  • Pulse Polarity Positive or Negative Pulse Delay 0.0005-999ms Envelope Mode Linear or exponential or any other curve
  • the interval between successive biphasic pulses may preferably be adjustable between 0.5 and 5 ms.
  • the characteristics of the envelopes, such as the repetition frequency, the stimulation fraction in the respiration cycle, the amplitude and the form of the envelope can be modified within the substantial range set forth above.
  • Pulse generator 18 and/or the interface 15 may be designed with a circuit and/or software, respectively, to prevent the misprogramming through keyboard 16 or component failure from causing excessively high stimulating parameters, e.g. excessive rates and amplitudes of the excitation pulses.
  • Fig. 8 shows exponential envelopes of biphasic pulses. It will be recognized that the response of a diaphragmic region will be different according to whether it receives pulse trains having envelopes a, b or c.
  • the device which has been described produces therefore a modulated stimulation with the possibility of The stimulation processing in the indicated register or the processing memorized on a disk under the name which is printed on keyboard 16 is transferred to the programmer memory and assigned to the interface monitor.
  • Each register can be selected independently of the state of the stimulator, whether it is in operation or not.
  • the stimulator restarts automatically at the end of the last stimulation cycle after the end of the data transfer.
  • the stimulator starts the execution of the treatment in the indicated register. If no register is indicated, the preceding register or the one urrently being used is selected.
  • the stimulator stops at the end of the stimulation cycle in progress.
  • Fig. 10 illustrates how individual pulse trains are sequentially applied to the six outputs of the device shown in Fig. 3 to effect a rhythmic contraction of the diaphragm.
  • a particular burst of pulses will be applied, for example, to a particular electrode.
  • Another different burst of pulses will then be applied to another electrode with this latter burst being delayed somewhat with respect to the first burst by, for example, 10 to 100 ms.
  • a third burst, also delayed, will then be applied to a third electrode and so forth.
  • These delays are shown in Fig. 10 for all six output pulse trains, and they may vary from 0 to 20% of each stimulation cycle.
  • the stimulation cycle may itself extend over 6 to 60% of the respiration cycle. In this way, electric energy will be applied to the diaphragm in a time delayed manner which will cause a contraction which is more regular and avoid ⁇ pasmatic contractions.
  • the waveforms of the pulses of the bursts can vary.
  • the first pulse can be of a weak amplitude and/or duration with the following pulses increasing in amplitude and/or duration.
  • the frequency of the pulses in a particular burst can vary within the burst. All of this can contribute to obtaining a respiration which is regular and smooth.
  • the total group of pulses delayed in time applied to all of the electrodes is of course repeated for each successive respiration as illustrated in Fig. 10.
  • the response of the patient to various characteristics will be observed, and the particular sequence which is the best suited to the particular patient will be noted and paced in memory. It is not otherwise possible to set forth a particular set of characteristics for the bursts which will function best for all patients or for all electrode emplacement arrangements.
  • the numerous possibilities of programming the device allows one to vary, in a continuous and independent manner, the amplitude, width and frequency of the pulses within the envelope.
  • the envelopes effect a global stimulation in regard to the part of the diaphragm associated with the electrode pair.
  • the start of each stimulation train can be programmed as to its arrival time at the stimulation point.
  • the programmer provides the means for entering and modifying the parameters and the stimulation control signals which appear on the screen of the interface device 15.
  • the stimulation characteristics namely the width, -duration and pulse frequency, will be calculated from a group of parameters and will be applied to one of the three independent registers 26, 27, 28 of stimulator 18.
  • stimulator 18 will commence stimulation by reading the register 26, 27 or 28 which is selected and generating electric pulses conforming with the contents of the register after execution of an appropriate instruction. Once the stimulator is functioning, the programmer can modify parameters and can execute other steps without affecting the stimulation function. The operations seen on the screen can be memorized on a disk, printed or programmed.
  • the quality of the contraction is variable as a function of diaphragm characteristics (a macroscopic determination by the surgeon);
  • the stimulation parameters are variable as function of diaphragm characteristics and the electrode implantation technique.
  • stimulation impulses which were biphasic, alternating, and with the optimum delay between the pulses within a train being on the order of 2 milliseconds.
  • Diaphragmic stimulation was attempted on 2 patients upon awakening from the anesthesia administered during surgery. There was noted under stimulation an increase of 2.41/mn on the spirometer compared with spontaneous respiration.
  • a second patient did not experience any painful phenomena during a stimulation which lasted 20 minutes. During this stimulation, expirations were noted having amplitudes which were greater following each stimulation, interspersed with spontaneous respiratory movements which were less pronounced.
  • diaphragm wire that carries several spaced electrodes and may be retracted through the skin is shown in Figs. 11 and 12.
  • This wire or lead is similar to the temporary heart pacing lead shown and described in U.S. Patent 4,341,226, and its insertion in the diaphragm is similar to the manner in which the referenced heart lead is inserted into the heart wall.
  • the proximal end of the lead contains a metallic, electrically conductive needle 40 which is used as a connector pin to couple the lead to the output terminals 23 of the pulse generator 18.
  • the needle 40 may have a weakened section 41 which may be severed after implant so that only the remaining section of the needle 40 is so used.
  • Needle 40 is attached to the flexible conductor 42 which runs the length of the temporary pacing lead and is attached to electrodes 43a, 43b, 43c and 43d, etc.
  • Insulating sheath 44 is of a - . 3-
  • Sheath 44 also insulates the conductor 42 extending between the electrodes 43a-43d.
  • a length of surgical thread 45 is attached between the electrode 43a and curved needle 46.
  • Surgical thread 45 has an outside diameter of about 0.35mm and is commonly available type such as polypropylene.
  • Helix 47 is molded into the surgical thread by applying hot air to the coil surgical thread.
  • Curved needle 46 is a standard surgical needle, the surgical thread 45 is attached to the curve needle 46 by a crimp at 48. Surgical needle 46 terminates in a hand-honed needle point 49.
  • Fig. 12 is a sectional view of electrode 43a.
  • the total length of electrode 43a is about 3mm.
  • the outside diameter of sheath 44 is approximately 0.7mm.
  • Sheath 44 extends between the proximal end of electrode 43a and the distal end of electrode 43b.
  • Conductor 42 passes through the lumens of sheath 44 and electrodes 43a-43d. In each case, the electrode is crimped down around the- conductor 42 in the manner depicted in Fig. 12.
  • the proximal end of surgical thread 45 is enlarged to produce fastener 45a. This may be accomplished by heating the proximal end of surgical thread 45 and applying it through force in the distal direction, thus flattening the end.
  • Fastener 45a is inserted into chamber 50 which lies within electrode 43a between the distal end of conductor 42 and the distal end of electrode 43a.
  • the distal end 51 of electrode 43a is swaged, producing the conical frustrum shape which securely holds fastener 45a.
  • the remaining electrodes 43b-43d have a shape similar to the electrode 43a except for the conical frustrum end 51.
  • the proximal and distal ends of these electrodes butt up against the insulating sheath 44 in the manner shown at the proximal end of electrode 43a in Fig. 12.
  • the temporary diaphragm wires of the type shown in Figs. 11 and 12 may have any number of electrodes 43 as may be found desirable, and the spacing between electrodes may be varied as considered desirable.
  • the electrodes 43 are electrically connected in series with the conductor 42 so that electrical impulses applied through the wire simultaneously stimulate a number of points in and around the diaphragm that the electrodes are threaded through.
  • one or more of the lead wires may be surgically attached to the diaphragm and coupled to one of the six or so outputs of the pulse generator 18.
  • the method of implantation is described more completely in the aforementioned U.S. Patent 4,341,226.
  • the helical coil 47 retains the electrodes in the diaphragm after the surgical thread 18 has been severed.
  • the length of the conductor extending between the final electrode 43d and the connector pin provided by the needle 40 is exited through the skin and coupled to the output of the external pulse generator.
  • the wire is retracted by pulling on the exteriorized portion of the lead and straightening the coil 47 which allows the entire lead to be retracted from the body.
  • one or more heart wires may be used as the active and indifferent electrode sets.

Abstract

A method and apparatus for diaphragmic stimulation for effecting respiration by applying electrical stimulation to the diaphragm by electrodes implanted in the diaphragm muscle. The invention includes a series of electrodes (2) arranged around the periphery of at least one half portion of the diaphragm, a stimulator (18) for generating electrical pulses connected to the electrodes (2) and an interface device (15) adapted to control the stimulator according to a predetermined program. The invention also includes a sensor (4) for sensing the respiratory condition of a patient and providing feedback for the interface device (15). The apparatus may be used temporarily during a patient's critical post-operative recovery period following chest surgery by use of leads sewn through the diaphragm and exiting through the skin. The temporary leads are attached to the external stimulator and may be retracted by traction after the patient resumes breathing independently.

Description

PROCESS AND APPARATUS FOR DIAPHRAGMIC STIMULATION
BACKGROUND OF THE INVENTION
1. Field of the Invention
The instant invention relates to the stimulation of human body organs and relates more particularly to diaphragmic stimulation to effect respiration.
2. Description of the Prior Art
In a substantial number of instances, patients who undergo thoracic surqery may, for a varying period following the surgical procedure, suffer a temporary paralysis of their respiratory system. Such patients require ventilatory support during the post-operative recovery period. That support, which involves inducing artificial respiration, is typically effected by a mechanical respirator which applies a cyclic pressure to the pulmonary cavities. This is done directly by forcing air or oxygen into the lungs via the nasopharynx and the trachea, or indirectly by enclosing either the chest or the entire body with the exception of the head and neck and cyclicly pressurizing the enclosure so that the resulting chest movements stimulates natural breathing.
Similarly, persons who suffer traumatic nerve damage or contract degenerative neurological diseases, such as amyotrophic lateral sclerosis ("Lou Gehrig's" disease) have total respiratory paralysis which requires ventilatory support at all times. Again, in such situations, mechanical respirators of one form or another are employed in the hospital or home setting. The mechanical respirators prevent the patients from being ambulatory during the time that they are needed. For this reason and for the discomfort and other complications of the mechanical respirators, many have sought, over the last thirty-five years, to develop a suitable, simple and effective replacement. For those patients who have temporary or permanent respiratory paralysis, yet retain intact respiratory muscles, diaphragm and innervating nerve trunks from the cervical cord, it has been proposed to induce artificial respiration by electrically stimulating the phrenic nerve which, in turn, induces diaphragmatic contraction. In 1948, Sarnoff et al published the first paper in modern times on electrophrenic stimulation ("Electrophrenic Respiration", The American Journal of Physiology, Vol. 155, No. 1, October 1, 1948). Sarnoff et al proposed that a wire electrode be looped around the exposed phrenic nerve and exited through the skin for attachment to a laboratory stimulator. Stimulating pulses of suitable length and configuration would be conducted to the phrenic nerve which, in turn, would innervate the diaphragm (see also U.S. Patent 2,532,788).
Since 1948, many papers have been published on experiments conducted employing the concept of directly stimulating the phrenic nerve to induce respiration. Long-term phrenic nerve stimulation for diaphram pacing was reported by Glenn et al in 1976 ("Long-Term Eventilator Support by Diaphragm Pacing in Quadriplegia" , Ann. Surgery, 183, 566-576). Others have suggested that the complete stimulator and electrode system be completely implanted, either with permanent batteries or with a system for transcutaneously powering the implanted circuitry and electrode system (see Talonen et al, "Transcutaneous, Dual-Channel Phrenic Nerve Stimulator for Diaphragm Pacing", Med. & Biol. Eng. and Comput., 1983, Vol. 21, pgs. 21-30).
These percutaneous or i plantable systems have not enjoyed a great deal of success, and mechanical respiration is the norm in medical practice today. In chronic implants, the phrenic nerve either becomes damaged or fatigued or otherwise fails to respond to the electrical stimulation after a period of time. In temporary situations, the complexity of the operation. J>
including the employment of electrodes wrapped around the phrenic nerve, makes it easier to simply employ the mechanical respirator until the patient recovers.
Although others have conducted experiments of direct electrical stimulation of the diaphragm muscle itself (see Macoviak et al, "Electrical Conditioning of In-Situ Skeletel Muscle Replacement of Myocardium", Journal of Surgical Research, Vol. 32, pgs. 429-439, 1982), no one apparently has appreciated the possibility of employing the direct stimulation of the diaphragm itself to effect artificial respiration on a temporary basis.
SUMMARY OF THE INVENTION This inventor has studied the possibility of stimulating the diaphragm in a manner which would provide the patient with efficient respiration assistance without discomfort (e.g., the "hiccup" effect) and which would employ a simple surgical procedure. Typically, the procedure would be conducted at the conclusion of open chest surgery to correct other problems.
The invention has as its object a process for diaphragmic stimulation adapted to assist respiratory movements of a patient characterized in that it consists in implanting, in the muscular tissues of at lest one-half portion of the diaphragm, stimulation electrodes distributed about the periphery of said half portion and in applying to each electrode a pulse train in which the amplitude, width and frequency of each pulse is variable in accordance with a predetermined program to provide each electrode with energy which is apropriate for the corresponding zone of the diaphragm.
A number of leads, e.g. 6 active and up to 6 passive leads, each with one or more electrodes, may be passed through and along the diaphragm muscle to provide many points of stimulation. Stimuli may be applied sequentially to each active lead to provide rhythmic contraction of the diaphragm. The time spacing between pulse trains as sequentially applied to the different electrodes, as well as the frequency or repetition sequence of the pulse trains, are variable in accordance with a predetermined program.
This repetition sequence is determined for each patient by testing the reactions of the patient to various stimulations. Once the best combination of values is determined, this combination is stored in a memory, and stimulation will then take place in accordance with these stored values.
An important advantage of the instant invention in regard to prior art respiration devices is as follows: in convention artificial respiration devices, air is brought into the lungs of the patient by pushing the diaphragm in a downward direction. This causes a problem as the externally directed force in the lungs of the patient also causes pressure to be applied against the auricle of the heart and thus interferes with blood circulation which in turn, retards the patient's rate of recovery. According to the invention, the diaphragm is displaced by electric means for the purpose of bringing air into the lungs. As there is no artificial forcing of air into the lungs, there is no pressure exerted against the heart and no obstacle to blood circulation.
Furthermore, this procedure avoids exposure of the phrenic nerve in the region of the neck and advantageously can be conducted following other chest surgery.
Following recovery by the patient, the transcutaneous leads can be withdrawn by traction similar to the manner in which a temporary heart pacing wire is retracted.
BRIEF DESCRIPTION OF THE DRAWINGS Other objects and many of the intended advantages of this invention will be readily appreciated as the same becomes better understood by reference to the following detailed description when considered in connection with the accompanying drawings in which like reference numerals - _?-
designate like parts throughout the figures thereof and wherein:
Fig. 1 is a schematic of the upper portion of the diaphragm in which are implanted stimulation electrodes according to the invention;
Fig. 2 is a schematic view of a bipolar electrode system implanted in the diaphragm muscle;
Fig. 3 is a schematic of a device for diaphragmic stimulation according to the invention;
Fig. 4 is a diagram showing a one type of pulse which can be used for diaphragmic stimulation;
Fig. 5 is another type of pulse which can be used for diaphragmic stimulation;
Figs. 6 and 7 show two recordings of stimulation pulse trains;
Fig. 8 shows examples of envelopes of stimulation signals;
Fig. 9 shows a simplified flowchart of the method of triggering the delivery of stimulating pulses in the absence of spontaneous respiration;
Fig. 10 illustrates how pulse trains are sequentially applied to the six outputs of the device shown in Fig. 3 to effect a rhythmic contraction of the diaphragm;
Fig. 11 shows a preferred unipolar, multi-electrode lead for implantation in the diaphragm for temporary stimulation; and
Fig. 12 shows a cross-section view of a portion of the lead of Fig. 11.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS In Fig. 1, there is shown schematically the muscle of diaphragm 1 with unipolar or bipolar electrodes 2 implanted in the muscle tissue at the external periphery of half of the diaphragm. There can be, for example, 20 such electrodes. Advantageously, sub-portions of these electrodes can be distributed along several lead wires, each having a common conductor. The inventor has noted that the quality of contraction depends upon the emplacement selected for the electrodes in the diaphragm as well as the form of the stimulation pulse trains. It has been noted that the implantation of stimulation electrodes in only a single half of the diaphragm yields good results, and this also limits the amount of surgical intervention, which is in any case- quite substantial.
In certain cases, as seen in Fig. 1, a diaphragm movement sensor 4 is placed in the other half of the diaphragm 5. This is so it often occurs that one side of the diaphragm functions normally with the other half being incapacitated and requiring stimulation. In such cases, the sensor 4 detects the normal movement of the diaphragm and emits signals which are utilized (in the system of Fig. 3) to trigger the stimulation of the other half of the diaphragm. through electrodes contacting it so as to obtain a natural rhythmn. The sensor 4 can be, for example, a pressure sensor, an impedance sensor, an EEG sensor or an activity sensor, and more than one can be provided. The activiation of the stimulating electrodes will therefore be dependent upon the mechanical or electrical activity in the diaphragm portion 5 detected by sensor 4. Of course, sensors and electrodes may be placed on or in both portions 3 and 5 of the diaphragm.
Alternatively, a suitable blood gas sensor, e.g., a sensor for pH, p02 or pC02 could be employed in the bloodstream to provide a control signal when oxygen tension falls below a preset limit to trigger operation of the respiration device of Fig. 3.
Fig. 2 shows schematically a bipolar single electrode lead of the type used in the invention. This lead is derived from the Medtronic temporary pacing lead model 6400 which is a temporary myocardial heart wire used for cardiac stimulation. In the Fig. 2 embodiment, the lead consists of two electrodes 6 and 7 which receive positive and negative stimulation signals, or act as the active and passive stimulating electrodes.
The bipolar lead includes ring electrodes 6 and 7 of biocompatible metal, such as for example, platinum, nonconductive filaments 14, each having a winding or coil 9 for fixing the electrodes into muscle 10, and lead bodies 11 extending to connector 12 for attachment to an excitation signal generator which will be discussed in connection with Fig. 3. Each lead body and electrode is drawn into the muscle 10 by perforating the muscle with its respective needle 13 and drawing the filament 14 and coil 9 into the muscle. The filament 14 is severed leaving the coil 9 in place to retain the electrode 6 or 7 in place. Other types of leads, for example, one or more unipolar leads having several electrodes of the type shown in Figs. 11 and 12 can also be used.
The electrodes can be implanted by open thoracic or open abdomenal surgical intervention. Implantation can also be effected by endoscopy, by pleuroscopy or peritonioscopy. The lead may later be retracted to pull the electrodes and coils out of the diaphragm and out of the patient's body through the skin incision.
Fig. 1 represents the electrodes which are implanted in the diaphram; however, these electrodes might also be affixed to a net or a plastic film element or similar, and this net or plastic film element might then be affixed to the diaphragm, the electrodes being placed in physical contact with the upper or lower portions of the diaphragm. In this manner, electric energy can be delivered to the diaphragm without a physical implantation of the electrodes within the diaphragmatic muscle. However, such an arrangement would not be retractable through the skin in the fashion that the temporary lead wire described herein may be used.
Fig. 3 shows the overall arrangement of the diaphragmatic stimulation device according to the invention. The stimulation apparatus shown in this figure includes a user interface 15 to which are connected a keyboard 16 and a printer 17. The interface 15 can be a micro-computer ELTEC system 7000 with a 6809 processor, a 64K memory and two 320K disc readers which effect the following functions:
Modification of stimulation parameters such as pulse amplitude, frequency and width and the envelope of the stimulation signals as well as the time interval between different pulse trains as well as the electrode choice;
Calculation and display of the stimulation data;
Data control, storing of the stimulation program, control of the printer, programming the stimulator.
The interface 15 is connected to a stimulator 18 through several, e.g. six, for example, independent floating unipolar or bipolar capacitive coupling outputs of the constant current or constant voltage type (or any other source of energy) connected to electrodes such as electrodes 2 of Fig. 1 implanted in patient P. The stimulator 18 includes a permanent stimulation path 19, a temporary stimulation path 20 and an emergency stimulation path 21; these three paths are connected to interface 15 by means of a commutator 22 and are connected to patient P by means of cable 23 and commutator 24. These commutators provide for stimulation independent of the interface 15 after programming. The stimulator 18 includes in addition an input 25 for remote control.
The control signal from the sensor 4 of Fig. 1 or other sensors as described above may be applied to the interface 15 which responds through suitable software to interrupt the delivery of stimulating or excitation pulse trains when the patient experiences spontaneous respiration or the blood gas levels are within normal ranqe. In Fig. 3, it is presumed that the control signal from sensor 4 is delivered in time sequence from patient P to interface 15 via cable 23 and stimulator 18. The signal from sensor 4 may instead be separately input directly into interface 15. Similarly signals developed by blood gas sensors or internal impedance plethysomograph signals may be developed from electrodes spaced apart on the diaphragm or in the chest cavity may be applied to interface 15. Alternatively an external thoracic belt with spaced electrodes can be used temporarily to develop an impedance plethysmograph control signal directly inputted into interface 15.
Fig. 9 illustrates how the sensor output is utilized to provide "inhibit" or "stimulate" control signals through commutator 22 to stimulator 18. In this example, the sensor develops an electrical signal representative of diaphragmic contraction, the signal having an amplitude representative of the strength of contraction. The interval between successive contractions is inverted to provide a contraction rate.
In Fig. 9, the sensor output (rate and amplitude) is first compared to a minimum rate; if the rate is below the minimum, a "stimulate" command is given to pulse generator 18. If the rate is above the minimum, then the amplitude is compared to a minimum amplitude. If the amplitude is below the minimum, then a "stimulate" command is given even though the rate, or interval between successive respirations, is acceptable. If the amplitude is above the minimum, then the "inhibit" command is given to the pulse generator 18. Thus, to inhibit, both rate and amplitude must be within normal ranges; to stimulate either rate or amplitude need be below normal.
Although, in the embodiment described, the control means for stimulation are external to the body, it is clear that the stimulator can also be implanted in the body and programmed from the exterior. Such implanted stimulators utilizing external programming means are widely used today in cardiac stimulation, with the program stored in the implanted stimulator being controlled and modified remotely from outside of the body by electromagnetic means, for example. These same principles can be applied to the diaphragmatic stimulator according to the instant invention.
The utilization of pulse trains instead of isolated pulses causes a diaphragm contraction which is regular and permits the generation of the necessary energy needed to overcome the elastic resistance of the tissues, the resistance of the displacement of the air and to assure the displacement of the abdominal mass.
The phenomena of muscular fatigue causes a reduction in the contraction response to an electric stimulation occasioned by irrevesible electro-chemical reactions at the muscle nerve electrode interface. In order to reduce this phenomena, the electric pulses must satisfy the following conditions:
Equilibrium in the electric charge within a pulse interval. The negative charge of the pulse which causes the muscle contraction should be balanced by the same charge quantity during the positive phase. Of course, the lead pulse which causes the contraction can be positive, and the following pulse can be negative;
The intensity of the current during the time of the positive and negative pulse phases must be the same.
A pulse which would satisfy the first condition is seen in Fig. 4 in which the area of the positive rectangular pulses 30 and the area of the negative triangular pulses 31 are equal. The second condition would be satisfied by the pulses shown in Fig. 5. A pulse which satisfies both conditions will provide better resistance to fatigue than a pulse which satisfies only the first condition.
It has been noted that the best results are probably obtained when the form of the positive and negative current pulse waves are identical, such as seen in Fig. 5. The response of the tissues to identical pulses of opposite polarity will be improved if a pulse is displaced in time with respect to the other pulse, and there will be no unbalanced tissue reaction which would occur if the current pulses were of different forms as seen in Fig. 4. The positive and negative pulses of Fig. 5 need not be adjacent to one another as seen in this figure but rather can be displaced with a time interval between the positive and negative pulses.
There will now be described the trains of pulses utilized in diaphragmatic stimulation, A train of pulses can be characterized by three parameters: the envelope of the amplitude of the pulses; the envelope of the width of the pulses; the envelope the frequency of the pulses. These three envelopes can include an increasing phase, a constant phase and a decreasing phase which can be linear or curved. One can vary the form of the envelopes and adjust them in a way to obtain the desired contraction of the diaphragm muscles.
In Figs. 6 and 7, there are shown two representations of actual recordings of pulse trains. Fig. 6 shows a monophase train of pulses having a linear amplitude envelope and a constant envelope as to pulse width and frequency.
Fig. 7 shows a biphasic train of pulses having a curved amplitude envelope, a curved frequency envelope and a constant pulse width envelope. The table which follows show, as an example, the most significant parameters and their particular range adapted to this particular - . __-
application.
TABLE
Variation Range Output Active-inactive
Repetition Frequency 0.1-200 bursts per minute Pulse Mode Mono or Biphasic or Alternative
Pulse Polarity Positive or Negative Pulse Delay 0.0005-999ms Envelope Mode Linear or exponential or any other curve
Pulse Amplitude 200-20mA Pulse Width 0,005-50ms Pulse Frequency 0.1-200Hz (preferably 4-50 Hz)
The interval between successive biphasic pulses may preferably be adjustable between 0.5 and 5 ms. The characteristics of the envelopes, such as the repetition frequency, the stimulation fraction in the respiration cycle, the amplitude and the form of the envelope can be modified within the substantial range set forth above. Pulse generator 18 and/or the interface 15 may be designed with a circuit and/or software, respectively, to prevent the misprogramming through keyboard 16 or component failure from causing excessively high stimulating parameters, e.g. excessive rates and amplitudes of the excitation pulses.
Examples of variations which engender corresponding variations in the stimulation energy of the associated electrode are represented in Fig. 8 which shows exponential envelopes of biphasic pulses. It will be recognized that the response of a diaphragmic region will be different according to whether it receives pulse trains having envelopes a, b or c.
The device which has been described produces therefore a modulated stimulation with the possibility of The stimulation processing in the indicated register or the processing memorized on a disk under the name which is printed on keyboard 16 is transferred to the programmer memory and assigned to the interface monitor.
Then the following instructions are given:
2 - "programs" - permanent "return" temporary emergency The operations on the screen are transferred to the selected stimulation register. Each register can be selected independently of the state of the stimulator, whether it is in operation or not.
If the operation is changed in the register in which the stimulator is functioning, the stimulator restarts automatically at the end of the last stimulation cycle after the end of the data transfer.
3 - "proceed" - permanent "return" temporary emergency The stimulator starts the execution of the treatment in the indicated register. If no register is indicated, the preceding register or the one urrently being used is selected.
4 - "stop" "return"
The stimulator stops at the end of the stimulation cycle in progress.
In order to test and verify the operation of the device, clinical experiments were conducted on 9 patients aged from 14 to 75 years. The choice criteria of the patients was not in regard to diaphragmic stimulation factors per se, but rather in regard to the possibility of implanting the electrodes without encountering the slightest risk to the patients. Of the 9 patients, 4 retained their electrodes for 3 to 7 days. The fundamental result was that it ws determined with certainty that there could be produced a diaphragmatic stimulation of a good quality in the sense of a muscular modification of the parameters of the pulse trains and of each pulse within the trains. Fig. 10 illustrates how individual pulse trains are sequentially applied to the six outputs of the device shown in Fig. 3 to effect a rhythmic contraction of the diaphragm.
In determining the waveforms of the pulses to be applied to the electrodes of Fig. 1, it is important to note that a particular burst of pulses will be applied, for example, to a particular electrode. Another different burst of pulses will then be applied to another electrode with this latter burst being delayed somewhat with respect to the first burst by, for example, 10 to 100 ms. A third burst, also delayed, will then be applied to a third electrode and so forth. These delays are shown in Fig. 10 for all six output pulse trains, and they may vary from 0 to 20% of each stimulation cycle. The stimulation cycle may itself extend over 6 to 60% of the respiration cycle. In this way, electric energy will be applied to the diaphragm in a time delayed manner which will cause a contraction which is more regular and avoid ≤pasmatic contractions.
Also, in regard to each particular pulse burst, applied to any particular electrode, the waveforms of the pulses of the bursts can vary. For example, the first pulse can be of a weak amplitude and/or duration with the following pulses increasing in amplitude and/or duration. Similarly, the frequency of the pulses in a particular burst can vary within the burst. All of this can contribute to obtaining a respiration which is regular and smooth.
The total group of pulses delayed in time applied to all of the electrodes is of course repeated for each successive respiration as illustrated in Fig. 10. In determining the appropriate characteristics of the bursts, the response of the patient to various characteristics will be observed, and the particular sequence which is the best suited to the particular patient will be noted and paced in memory. It is not otherwise possible to set forth a particular set of characteristics for the bursts which will function best for all patients or for all electrode emplacement arrangements.
The numerous possibilities of programming the device allows one to vary, in a continuous and independent manner, the amplitude, width and frequency of the pulses within the envelope. The envelopes effect a global stimulation in regard to the part of the diaphragm associated with the electrode pair. The start of each stimulation train can be programmed as to its arrival time at the stimulation point.
The Operation of the Interface 15
The programmer provides the means for entering and modifying the parameters and the stimulation control signals which appear on the screen of the interface device 15. In response to an appropriate instruction, the stimulation characteristics, namely the width, -duration and pulse frequency, will be calculated from a group of parameters and will be applied to one of the three independent registers 26, 27, 28 of stimulator 18.
Once the three registers are loaded, stimulator 18 will commence stimulation by reading the register 26, 27 or 28 which is selected and generating electric pulses conforming with the contents of the register after execution of an appropriate instruction. Once the stimulator is functioning, the programmer can modify parameters and can execute other steps without affecting the stimulation function. The operations seen on the screen can be memorized on a disk, printed or programmed.
An example of the available program controls is given below. 1 - "stimulation request" - permanent "return" temporary emergency name ~ _ β -
stimulation which restores normal respiratory movement. Although the types of diaphragms were quite different, a respiratory movement was always produceable after the patient had been appropriately tested.
The findings were the following:
The quality of the contraction is variable as a function of diaphragm characteristics (a macroscopic determination by the surgeon);
The stimulation parameters are variable as function of diaphragm characteristics and the electrode implantation technique.
The best contraction observed was with stimulation impulses which were biphasic, alternating, and with the optimum delay between the pulses within a train being on the order of 2 milliseconds.
After various attempts, all types of contractions were obtained: tremulations, partial contractions in the zone peripheral to each electrode, and hiccups. When the parameters of the envelope of stimulation were correctly determined, the diaphragmic contraction obtained was progressive, global, homogenous and without the fatigue phenomena.
Diaphragmic stimulation was attempted on 2 patients upon awakening from the anesthesia administered during surgery. There was noted under stimulation an increase of 2.41/mn on the spirometer compared with spontaneous respiration.
So as to be able properly to interpret the experimentation, in particular because of the painful post-operative period, stimulations were again effected some time after the intervention. In regard to the same patient who had been tested upon awakening, each stimulation was followed by a better quality expiration and an amelioration of the useful yield. In regard to the same patient, the initial stimulation with the same threshold value as per-operatory was painful, but if the ! 7
threshold values were increased progresively, but rather rapidly, the procedure was no longer painful.
A second patient did not experience any painful phenomena during a stimulation which lasted 20 minutes. During this stimulation, expirations were noted having amplitudes which were greater following each stimulation, interspersed with spontaneous respiratory movements which were less pronounced.
It is noted that, according to this invention, better results can be obtained by reducing,* or otherwise modifying, the cyclical stimulation relation. The optimum procedure is not necessarily to stimulate the diaphragm for each inhalation but rather, for some patients, the best results can be obtained by one or more artificial stimulations which can be followed by one or more natural respiratory movements, with another stimulation then being applied and so forth. Such sequences can be programmed in advance with the apparatus according to the invention.
The Retractable Diaphragm Wire
A preferred form of diaphragm wire that carries several spaced electrodes and may be retracted through the skin is shown in Figs. 11 and 12. This wire or lead is similar to the temporary heart pacing lead shown and described in U.S. Patent 4,341,226, and its insertion in the diaphragm is similar to the manner in which the referenced heart lead is inserted into the heart wall.
Referring to Fig. 11, the proximal end of the lead contains a metallic, electrically conductive needle 40 which is used as a connector pin to couple the lead to the output terminals 23 of the pulse generator 18. The needle 40 may have a weakened section 41 which may be severed after implant so that only the remaining section of the needle 40 is so used. Needle 40 is attached to the flexible conductor 42 which runs the length of the temporary pacing lead and is attached to electrodes 43a, 43b, 43c and 43d, etc. Insulating sheath 44 is of a - . 3-
material substantially inert to body fluids such as polyethylene. Sheath 44 also insulates the conductor 42 extending between the electrodes 43a-43d. A length of surgical thread 45 is attached between the electrode 43a and curved needle 46. Surgical thread 45 has an outside diameter of about 0.35mm and is commonly available type such as polypropylene. Helix 47 is molded into the surgical thread by applying hot air to the coil surgical thread. Curved needle 46 is a standard surgical needle, the surgical thread 45 is attached to the curve needle 46 by a crimp at 48. Surgical needle 46 terminates in a hand-honed needle point 49.
Fig. 12 is a sectional view of electrode 43a. The total length of electrode 43a is about 3mm. The outside diameter of sheath 44 is approximately 0.7mm. Sheath 44 extends between the proximal end of electrode 43a and the distal end of electrode 43b. Conductor 42 passes through the lumens of sheath 44 and electrodes 43a-43d. In each case, the electrode is crimped down around the- conductor 42 in the manner depicted in Fig. 12. The proximal end of surgical thread 45 is enlarged to produce fastener 45a. This may be accomplished by heating the proximal end of surgical thread 45 and applying it through force in the distal direction, thus flattening the end.
Fastener 45a is inserted into chamber 50 which lies within electrode 43a between the distal end of conductor 42 and the distal end of electrode 43a. The distal end 51 of electrode 43a is swaged, producing the conical frustrum shape which securely holds fastener 45a.
The remaining electrodes 43b-43d have a shape similar to the electrode 43a except for the conical frustrum end 51. The proximal and distal ends of these electrodes butt up against the insulating sheath 44 in the manner shown at the proximal end of electrode 43a in Fig. 12.
The temporary diaphragm wires of the type shown in Figs. 11 and 12 may have any number of electrodes 43 as may be found desirable, and the spacing between electrodes may be varied as considered desirable. In each case, the electrodes 43 are electrically connected in series with the conductor 42 so that electrical impulses applied through the wire simultaneously stimulate a number of points in and around the diaphragm that the electrodes are threaded through.
In use, one or more of the lead wires may be surgically attached to the diaphragm and coupled to one of the six or so outputs of the pulse generator 18. The method of implantation is described more completely in the aforementioned U.S. Patent 4,341,226. As stated earlier, the helical coil 47 retains the electrodes in the diaphragm after the surgical thread 18 has been severed. The length of the conductor extending between the final electrode 43d and the connector pin provided by the needle 40 is exited through the skin and coupled to the output of the external pulse generator. The wire is retracted by pulling on the exteriorized portion of the lead and straightening the coil 47 which allows the entire lead to be retracted from the body. For bipolar stimulation, one or more heart wires may be used as the active and indifferent electrode sets.

Claims

What is Claimed is:
1. A method of diaphragmatic stimulation adapted to assist respiratory movements of a patient including the steps of: implanting into the muscle tissues of at least one-half portion of the diaphragm, stimulation electrodes distributed about the periphery of said half portion; and applying to the stimulation electrodes, in accordance with a predetermined sequence, particular stimulation pulses to provide to each electrode energy appropriate for stimulating the corresponding zone of the diaphragm for producing regular respiration.
2. A method according to claim 1 wherein the stimulation pulses applied to electrodes according to a predetermined sequence are constituted by monophase or biphase pulse trains, or alternating monophase - biphase pulse trains, modulated as to width and/or amplitude and/or frequency, with a delay being provided between the pulse trains arriving at different electrodes, the respiration frequency of the pulse trains determining the respiration cycle.
3. A method according to claim 2 wherein the envelopes of said pulse trains include increasing and decreasing portions which are linear or curvilinear.
4. A method according to claims 1 including the steps of: implantinq into the half of the diaphragm opposite to the half having the electrodes at least one sensor for sensing the diaphragm activity; and 2.
applying said stimulation pulses to said stimulation electrodes dependent upon the signals produced by said sensor to provide synchronous contraction of both halves of the diaphragm.
5. A method according to claim 2 including the steps of: implanting into the half of the diaphragm opposite to the half having the electrodes at least one sensor for sensing the diaphragm activity; and applying said stimulation pulses to said stimulation electrodes dependent upon the signals produced by said sensor to provide synchronous contraction of both halves of the diaphragm.
6. A method according to claim 3 including the steps of: implanting into the half of the diaphragm opposite to the half having the electrodes at least one sensor for sensing the diaphragm activity; and applying said stimulation pulses to said stimulation electrodes dependent upon the signals produced by said sensor to provide synchronous contraction of both halves of the diaphragm.
7. A method according to claim 1 including the steps of: implanting one or more lead wires, each having one or more exposed electrodes and a length of insulated conductor so that the electrodes are in contact with the muscle tissues of the diaphragm and extending the insulated conductor, in each case, through an incision in the patient's skin; -11-
closing the incision and applying said stimulation pulses to the electrodes in said predetermined sequence for a period of time, and, upon conclusion of treatment, retracting each lead wire through the incision by traction applied to the exposed insulated conductor.
8. A method according to claim 1 including the steps of: implanting one or more lead wires, each having one or more exposed electrodes and a length of insulated conductor so that the electrodes are in contact with the muscle tissues of the diaphragm and extending the insulated conductor, in each case, through an incision in the patient's skin; implanting into the half of the diaphragm opposite to the half having the electrodes at least one sensor for sensing the diaphragm activity; closing the incision and applying said stimulation pulses to the electrodes dependent upon the signals produced by said sensor to provide synchronous contraction of both halves of the diaphragm; and retracting each lead wire through the incision by traction applied to the exposed insulated conductor.
9. A method according to claim 2 including the steps of: implanting one or more lead wires, each having one or more exposed electrodes and a lenqth of insulated conductor so that the electrodes are in contact with the muscle tissues of the diaphragm and extending the insulated conductor, in each case, through an incision in the patient's skin; implanting into the half of the diaphragm opposite to the half having the electrodes at least one sensor for sensing the diaphragm activity; closing the incision and applying said stimulation pulses to the electrodes dependent upon the signals produced by said sensor to provide synchronous contraction of both halves of the diaphragm; and retracting each lead wire through the incision by traction applied to the exposed insulated conductor.
10. A method according to claim 3 including the steps of: implanting one or more lead wires, each having one or more exposed electrodes and a length of insulated conductor so that the electrodes are in contact with the muscle tissues of the diaphragm and extending the insulated conductor, in each case, through an incision in the patient's skin; implanting into the half of the diaphragm opposite to the half having the electrodes at least one sensor for sensing the diaphragm activity; closing the incision and applying said stimulation pulses to the electrodes dependent upon the signals produced by said sensor to provide synchronous contraction of both halves of the diaphragm; and retracting each lead wire through the incision by traction applied to the exposed insulated conductor.
11. A method according to claim 1 including the steps of: attaching or implanting a sensor on or in the body of the patient for detecting a physiological parameter associated with respiration activity and developing a respiration rate control signal reflecting the interval between successive spontaneous respirations of the patient; and applying said stimulation pulses to said stimulation electrodes when the respiration rate control signal reflects an interval greater than a predetermined reerence interval.
12. A method according to claim 11 including the steps of: developing a respiration amplitude control signal having a value reflecting the strength of contraction of the diaphragm; and applying said stimulation pulses to said stimulation electrodes when the value of said respiration amplitude control signal indicates the need for respiratory assistance.
13. A method according to claim 11 wherein the measured respiratory parameter comprises the EEG of the diaphragm, an impedance plethysmograph signal derived from spaced apart electrodes implanted on or adjacent to the diaphragm or worn on the patient's thorax and/or a motion sensor implanted adjacent to or on the diaphragm.
14. A method according to claim 1 including the steps of: attaching or implanting a sensor on or in the body of the patient for detecting a "physiological parameter associated with respiration activity and developing a respiration amplitude control signal having a value reflecting the strength of contraction of the diaphragm; and applying said stimulation pulses to said stimulation electrodes when the value of said respiration amplitude control signal indicates the need for respiratory assistance.
15. A method according to claim 1 including the steps of: attaching or implanting a sensor on or in the body of the patient for detecting a physiological parameter associated with respiration activity, e.g., muscular EEG, impedance or mechanical activity caused by contraction of all or part of the diaphragm; and applying said stimulation pulses to said stimulation electrodes dependent upon the signals produced by said sensor to provide regular and smooth contraction of said diaphragm.
16. A method according to claim 1 including the steps of: implanting a sensor in the bloodstream of the patient for detecting a physiological blood parameter associated with respiration and developing a control signal in response thereto; and applying said stimulation pulses to said stimulation electrodes when the control signal reflects a blood parameter indicative of the need for respiration.
17. A method according to claim 16 wherein the sensor detects blood pH, p02 and/or pC02.
18. A method of diaphragmatic stimulation adapted to assist respiratory movements of a patient including the steps of: implanting one or more lead wires, each having one or more exposed electrodes and a length of insulated 2
conductor so that the electrodes are in contact with the muscle tissues of the diaphragm and extending the insulated conductor, in each case, through an incision in the patient's skin; closing the incision and applying particular stimulation pulses to the stimulation electrodes, in accordance with a predetermined sequence, to provide to each electrode energy appropriate for stimulating the corresponding zone of the diaphragm for producing regular respiration; and retracting each lead wire through the incision by traction applied to the exposed insulator conductor upon completion of treatment.
19. A method according to claim 18 wherein the stimulation pulses applied to electrodes according to a predetermined sequence are constituted by monophase or biphase pulse trains, or alternating monphase - biphase pulse trains, modulated as to width and/or amplitude and/or frequency, with a delay being provided between the pulse trains arriving at different electrodes, the respiration frequency of the pulse trains determining the respiration cycle.
20. A method according to claim 19 wherein the envelopes of said pulse trains include increasing and decreasing portions which are linear or curvilinear.
21. A method in accordance with claim 19 further comprising the step of: limiting the respiration frequency and respiration cycle to a predetermined frequency and cycle length to prevent discomfort and danger to the patient. 2J
22. A method according to claim 18 including the steps of: deriving a respiration rate reflecting the interval between successive spontaneous respirations of the patient; and applying said stimulation pulses to said stimulation electrodes when the respiration rate falls below a predetermined respiration rate.
23. A method according to claim 18 including the steps of: attaching or implanting a sensor on or in the body of the patient for detecting a physiological parameter associated with respiration activity and developing a respiration rate control signal reflecting the interval between successive spontaneous respirations of the patient; and applying said stimulation pulses to said stimulation electrodes when the respiration rate control signal reflects an interval greater than a predetermined reference interval.
24. A method according to claim 23 including the steps of: developing a respiration amplitude control signal having a value reflecting the strength of contraction of the diaphragm; and applying said stimulation pulses to said stimulation electrodes when the value of said respiration amplitude control signal indicates the need for respiratory assistance.
25. A method according to claim 23 wherein the measured respiratory parameter comprises the EEG of the - _i o -
diaphragm, an impedance plethysmograph signal derived from spaced apart electrodes implanted on or adjacent to the diaphragm or worn on the patient's thorax and/or a motion sensor implanted adjacent to or on the diaphragm.
26. A method according to claim 18 including the steps of: attaching or implanting a sensor on or in the body of the patient for detecting a physiological parameter associated with respiration activity and developing a respiration amplitude control signal having < value reflecting the strength of contraction of the diaphragm; and applying said stimulation pulses to said stimulation electrodes when the value of said respiration amplitude control signal indicates the need for respiratory assistance.
27. A method according to claim 18 including the steps of: attaching or implanting a sensor on or in the body of the patient for detecting a physiological parameter associated with respiration activity, e.g., muscular EEG, impedance or mechanical activity caused by contraction of all or part of the diaphragm; and applying said stimulation pulses to said stimulation electrodes dependent upon the signals produced by said sensor to provide regular and smooth contraction of said diaphragm.
28. A method according to claim 18 including the steps of: implanting a sensor in the bloodstream of the patient for detecting a physiological blood parameter 23
associated with respiration and developing a control signal in response thereto; and applying said stimulation pulses to said stimulation electrodes when the control signal reflects a blood parameter indicative of the need for respiration.
29. A method according to claim 28 wherein the sensor detects blood pH, p02 and/or pC02.
30. A diaphragmatic stimulation device for assisting respiratory movements of a patient comprising: lead means having electrode means for contacting diaphragmatic muscle tissue; stimulating means for applying to said electrode means, in accordance with a predetermined sequence, particular stimulation pulses to provide each electrode means with energy appropriate for stimulating the corresponding zone of the diaphragm for producing regular respiration; and interface means for providing command signals to said stimulating means to establish the predetermined sequence and energy of stimulation pulses.
31. A device according to claim 30 wherein the stimulator means includes three paths for permanent, temporary and emergency stimulation, and means for connecting these paths to said interface means and to said lead means.
32. A device according to claim 30 wherein said electrode means are bipolar and are each formed of two electrode elements of biocompatible metal having means for fixation into' the muscular tissues and having curved 32
needles and transcutaneous needles connected to a connector for connection with the stimulator means.
33. A device according to claim 32 wherein the stimulator means includes three paths for permanent, temporary and emergency stimulation, and means for connecting these paths to said interface means and to said lead means to accomplish the desired mode of stimulation.
34. A device according to claim 30 further comprising: sensor means for detecting the activity of at least one-half portion of the diaphragm; and further means for connecting said sensor means to said stimulator means for triggering the stimulation pulses in one or both halves of the diaphragm following the output signal of said sensor means detecting natural diaphragm activity in at least one-half of the diaphragm to provide synchronous contraction of both halves of the diaphragm.
35. A device according to claim 34 further comprising: further sensor means for detecting the activity of the other half portion of the diaphragm.
36. A device according to claim 30 wherein said lead means is adapted to be placed against the diaphragm with said electrode means in contact with the external surface of the diaphragm.
37. A device according to claim 30 wherein: _ 1
said lead means comprises a plurality of spaced apart electrodes in contact with diaphragm tissue; said stimulator means includes means for applying bursts of stimulation pulses to said electrodes with a delay between bursts applied to different electrodes so as to provide a rhythmic contraction of the diaphragm.
38. A device according to claim 37 wherein the bursts consist of stimulation pulses having a variable frequency and/or amplitude and/or duration.
39. A device according to claim 37 wherein the stimulation pulses have positive and negative current pulse waveforms which are substantially identical.
40. A device according to claim 30 wherein the stimulation pulses applied to said electrode means according to a predetermined sequence are constituted by monophase or biphase pulse trains, or alternating monophase - biphase pulse trains, modulated as to width and/or amplitude and/or frequency, with a delay being provided between the pulse trains arriving at different electrodes, the respiration frequency of the pulse trains determining the respiration cycle.
41. A device according to claim 40 wherein the envelopes of said pulse trains include increasing and decreasing portions which are linear or curvilinear.
42. A device according to claim 30 wherein the electrodes are carried by lead means adapted to be placed against the diaphragm with the electrodes in contact with the external surface of the diaphragm.
43. A device according to claim 30 further comprising: sensor means attached or implanted on or in the body of the patient for detecting a physiological parameter associated with respiration activity and developing a respiration rate control signal reflecting the interval between successive spontaneous respirations of the patient; and means for applying said stimulation pulses to said stimulation electrodes when the respiration rate control signal reflects an interval greater than a predetermined reference interval.
44. A device according to claim 43 further comprising: means responsive to said sensor means for developing a respiration amplitude control signal having a value reflecting the strength of contraction of the diaphragm; and means for applying said stimulation pulses to said stimulation electrodes when the value of said respiration amplitude control signal indicates the need for respiratory assistance.
45. A device according to claim 43 wherein said sensor means detects the EEG of the diaphragm or derives an impedance plethysmograph signal from spaced apart electrodes implanted on or adjacent to the diaphragm or worn on the patient's thorax and/or comprises a motion sensor implanted adjacent to or on the diaphragm for developing a signal in response to movement of the diaphragm.
46. A device according to claim 30 further comprising: sensor means attached to or implanted in the body of the patient for detecting a physiological parameter associated with respiration activity and developing a respiration amplitude control signal having value reflecting the strength of contraction of the diaphragm; and means for applying said stimulation pulses to said stimulation electrodes when the value of said respiration amplitude control signal indicates the need for respiratory assistance.
47. A d-evice according to claim 46 wherein said sensor means detects the EEG of the diaphragm or derives an impedance plethysomograph signal from spaced apart electrodes implanted on or adjacent to the diaphragm or worn on the patient's thorax and/or comprises a motion sensor implanted adjacent to or on the diaphragm for developing a signal in response to movement of the diaphragm.
48. A device according to claim 30 further comprising: sensor means adapted to be implemented in the bloodstream of the patient for detecting a physiological blood parameter associated with respiration and developing a control signal in response thereto; and means for applying said stimulation pulses to said stimulation electrodes when the control signal 3'4
reflects a blood parameter indicative of the need for respiration.
49. A method according to claim 48 wherein the sensor detects blood pH, p02 and/or pC02.
PCT/US1985/001156 1984-06-21 1985-06-20 Process and apparatus for diaphragmic stimulation WO1986000234A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE8585903508T DE3581284D1 (en) 1984-06-21 1985-06-20 METHOD AND DEVICE FOR STIMULATING THE DIAPHRAGMA.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8409785A FR2566276B1 (en) 1984-06-21 1984-06-21 DIAPHRAGMATIC STIMULATION METHOD AND APPARATUS
FR84/09785 1984-06-21

Publications (1)

Publication Number Publication Date
WO1986000234A1 true WO1986000234A1 (en) 1986-01-16

Family

ID=9305289

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1985/001156 WO1986000234A1 (en) 1984-06-21 1985-06-20 Process and apparatus for diaphragmic stimulation

Country Status (5)

Country Link
EP (1) EP0190195B1 (en)
JP (1) JPH064098B2 (en)
DE (1) DE3581284D1 (en)
FR (1) FR2566276B1 (en)
WO (1) WO1986000234A1 (en)

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4827935A (en) * 1986-04-24 1989-05-09 Purdue Research Foundation Demand electroventilator
EP0494787A1 (en) * 1991-01-09 1992-07-15 Medtronic, Inc. Servo muscle control
WO1992021407A1 (en) * 1991-05-28 1992-12-10 Medtronic, Inc. Airway feedback measurement
US5211173A (en) * 1991-01-09 1993-05-18 Medtronic, Inc. Servo muscle control
US5501703A (en) * 1994-01-24 1996-03-26 Medtronic, Inc. Multichannel apparatus for epidural spinal cord stimulator
US5678535A (en) * 1995-04-21 1997-10-21 Dimarco; Anthony Fortunato Method and apparatus for electrical stimulation of the respiratory muscles to achieve artificial ventilation in a patient
EP0838233A1 (en) * 1996-10-18 1998-04-29 Pacesetter AB A tachycardia eliminating apparatus, stimulating the respiratory system
US5895416A (en) * 1997-03-12 1999-04-20 Medtronic, Inc. Method and apparatus for controlling and steering an electric field
WO2002004066A1 (en) * 2000-07-12 2002-01-17 Wada, Hiromi Body-buried electrode
US6360740B1 (en) 1998-10-14 2002-03-26 Siemens Elema Ab Method and apparatus for assisted breathing
EP1940504A1 (en) * 2005-05-13 2008-07-09 Neurosignal Technologies, Inc Method and system to control respiration by means of simulated neuro-electrical coded signals
US7672729B2 (en) 2004-09-10 2010-03-02 Pacesetter, Inc. Multi-variable feedback control of stimulation for inspiratory facilitation
US7962215B2 (en) 2004-07-23 2011-06-14 Synapse Biomedical, Inc. Ventilatory assist system and methods to improve respiratory function
US8406885B2 (en) 2003-07-23 2013-03-26 Synapse Biomedical, Inc. System and method for conditioning a diaphragm of a patient
US8428726B2 (en) 2007-10-30 2013-04-23 Synapse Biomedical, Inc. Device and method of neuromodulation to effect a functionally restorative adaption of the neuromuscular system
US8478412B2 (en) 2007-10-30 2013-07-02 Synapse Biomedical, Inc. Method of improving sleep disordered breathing
US8596270B2 (en) 2009-08-20 2013-12-03 Covidien Lp Systems and methods for controlling a ventilator
US8862196B2 (en) 2001-05-17 2014-10-14 Lawrence A. Lynn System and method for automatic detection of a plurality of SP02 time series pattern types
US9042952B2 (en) 1997-01-27 2015-05-26 Lawrence A. Lynn System and method for automatic detection of a plurality of SPO2 time series pattern types
US9050005B2 (en) 2005-08-25 2015-06-09 Synapse Biomedical, Inc. Method and apparatus for transgastric neurostimulation
US9053222B2 (en) 2002-05-17 2015-06-09 Lawrence A. Lynn Patient safety processor
US9079016B2 (en) 2007-02-05 2015-07-14 Synapse Biomedical, Inc. Removable intramuscular electrode
US9259573B2 (en) 2003-10-15 2016-02-16 Rmx, Llc Device and method for manipulating exhalation
US9370657B2 (en) 2003-10-15 2016-06-21 Rmx, Llc Device for manipulating tidal volume and breathing entrainment
US9468378B2 (en) 1997-01-27 2016-10-18 Lawrence A. Lynn Airway instability detection system and method
US9521971B2 (en) 1997-07-14 2016-12-20 Lawrence A. Lynn System and method for automatic detection of a plurality of SPO2 time series pattern types
US9820671B2 (en) 2007-05-17 2017-11-21 Synapse Biomedical, Inc. Devices and methods for assessing motor point electromyogram as a biomarker
US10354753B2 (en) 2001-05-17 2019-07-16 Lawrence A. Lynn Medical failure pattern search engine
US10857363B2 (en) 2014-08-26 2020-12-08 Rmx, Llc Devices and methods for reducing intrathoracic pressure
US11266838B1 (en) 2019-06-21 2022-03-08 Rmx, Llc Airway diagnostics utilizing phrenic nerve stimulation device and method
US20220111202A1 (en) * 2009-09-10 2022-04-14 Zoll Respicardia, Inc. Respiratory Rectification
US11471683B2 (en) 2019-01-29 2022-10-18 Synapse Biomedical, Inc. Systems and methods for treating sleep apnea using neuromodulation

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014032002A2 (en) * 2012-06-21 2017-06-27 Univ Fraser Simon transvascular diaphragm stimulation systems and methods of use
AU2015208640B2 (en) * 2014-01-21 2020-02-20 Lungpacer Medical Inc. Systems and related methods for optimization of multi-electrode nerve pacing
US11207517B2 (en) * 2017-07-06 2021-12-28 Stimdia Medical, Inc. Percutaneous electrical phrenic nerve stimulation system

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2532788A (en) * 1948-01-03 1950-12-05 Stanley J Sarnoff Artificial respiration by electronic stimulation
US3593718A (en) * 1967-07-13 1971-07-20 Biocybernetics Inc Physiologically controlled cardiac pacer
US3730173A (en) * 1970-02-02 1973-05-01 Ahldea Corp Stimulation method and apparatus for attempting to return a physiological parameter of a patient to normal
US3773051A (en) * 1972-03-01 1973-11-20 Research Corp Method and apparatus for stimulation of body tissue
FR2257312A1 (en) * 1974-01-16 1975-08-08 Zacouto Fred Electromedical heart treatment appts. - generates electric field between peripheral electrode and one implanted in heart cavity
GB1410761A (en) * 1971-08-06 1975-10-22 Atlantic Richfield Co Implantable respiratory pacer
US4009721A (en) * 1975-04-24 1977-03-01 Pacer S.N.C. Of Cerchiai Vanna & C. Artificial pacemaker
US4013068A (en) * 1974-10-15 1977-03-22 Settle Wayne L Electroencephalographic activated control system
US4308870A (en) * 1980-06-04 1982-01-05 The Kendall Company Vital signs monitor
US4341226A (en) * 1980-09-22 1982-07-27 Medtronic, Inc. Temporary lead with insertion tool
US4467807A (en) * 1981-11-23 1984-08-28 Medtronic, Inc. Rate adaptive demand pacemaker

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2661744A (en) * 1950-05-09 1953-12-08 Relaxacizor Inc Device for treatment of the muscles of the upper torso
LU30805A1 (en) * 1950-06-13
JPS4992885A (en) * 1972-08-04 1974-09-04
US3851651A (en) * 1972-12-22 1974-12-03 P Icenbice Facial stimulating apparatus having sequentially energized electrodes
AT330342B (en) * 1973-08-10 1976-06-25 Herwig Dipl Ing Dr Techn Thoma DEVICE FOR LONG-TERM ELECTRIC LONG-TERM ELECTRICAL STIMULATION CURRENT STIMULATION OF AN INDICATIVE OBJECT, SUCH AS NERVES AND MUSCLES, VARIABLE AND TIME-VARIABLE
FR2279376A1 (en) * 1974-07-26 1976-02-20 Elbaz Jean Electronic control of contraction of facial muscles - where only one of facial nerves is suffering from partial or total lesion
FR2305168A1 (en) * 1975-03-24 1976-10-22 Ieram Sarl Patient respiration stimulation system - uses catheters with electrodes near phrenic nerves thrust into subclavian vein to receive electrical impulses
FR2433950A1 (en) * 1978-08-22 1980-03-21 Inst Creation Etu Tech Lower limb HF blood circulation booster - has frequency generator connected sequentially to different electrodes in overlapping manner
FR2493154A1 (en) * 1980-11-05 1982-05-07 Berthelin Francis Electrical respiratory stimulator - has two pairs of electrodes, placed at level of muscles of patient, supplied with AC of slightly varying frequencies
GB2092004B (en) * 1981-01-29 1985-05-15 Bio Medical Res Ltd Muscle stimulating apparatus
DE3130104A1 (en) * 1981-07-30 1983-02-17 Messerschmitt-Bölkow-Blohm GmbH, 8000 München ARRANGEMENT FOR STIMULATING A HUMAN MUSCLE

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2532788A (en) * 1948-01-03 1950-12-05 Stanley J Sarnoff Artificial respiration by electronic stimulation
US3593718A (en) * 1967-07-13 1971-07-20 Biocybernetics Inc Physiologically controlled cardiac pacer
US3730173A (en) * 1970-02-02 1973-05-01 Ahldea Corp Stimulation method and apparatus for attempting to return a physiological parameter of a patient to normal
GB1410761A (en) * 1971-08-06 1975-10-22 Atlantic Richfield Co Implantable respiratory pacer
US3773051A (en) * 1972-03-01 1973-11-20 Research Corp Method and apparatus for stimulation of body tissue
FR2257312A1 (en) * 1974-01-16 1975-08-08 Zacouto Fred Electromedical heart treatment appts. - generates electric field between peripheral electrode and one implanted in heart cavity
US4013068A (en) * 1974-10-15 1977-03-22 Settle Wayne L Electroencephalographic activated control system
US4009721A (en) * 1975-04-24 1977-03-01 Pacer S.N.C. Of Cerchiai Vanna & C. Artificial pacemaker
US4308870A (en) * 1980-06-04 1982-01-05 The Kendall Company Vital signs monitor
US4341226A (en) * 1980-09-22 1982-07-27 Medtronic, Inc. Temporary lead with insertion tool
US4467807A (en) * 1981-11-23 1984-08-28 Medtronic, Inc. Rate adaptive demand pacemaker
US4467807B1 (en) * 1981-11-23 1992-06-30 Medtronics Inc

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP0190195A4 *

Cited By (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4827935A (en) * 1986-04-24 1989-05-09 Purdue Research Foundation Demand electroventilator
EP0494787A1 (en) * 1991-01-09 1992-07-15 Medtronic, Inc. Servo muscle control
US5211173A (en) * 1991-01-09 1993-05-18 Medtronic, Inc. Servo muscle control
US5300094A (en) * 1991-01-09 1994-04-05 Medtronic, Inc. Servo muscle control
WO1992021407A1 (en) * 1991-05-28 1992-12-10 Medtronic, Inc. Airway feedback measurement
US5174287A (en) * 1991-05-28 1992-12-29 Medtronic, Inc. Airway feedback measurement system responsive to detected inspiration and obstructive apnea event
AU649145B2 (en) * 1991-05-28 1994-05-12 Medtronic, Inc. Airway feedback measurement
US5501703A (en) * 1994-01-24 1996-03-26 Medtronic, Inc. Multichannel apparatus for epidural spinal cord stimulator
US5911218A (en) * 1995-04-21 1999-06-15 Dimarco; Anthony Fortunato Method and apparatus for electrical stimulation of the respiratory muscles to achieve artificial ventilation in a patient
US5678535A (en) * 1995-04-21 1997-10-21 Dimarco; Anthony Fortunato Method and apparatus for electrical stimulation of the respiratory muscles to achieve artificial ventilation in a patient
US5814086A (en) * 1996-10-18 1998-09-29 Pacesetter Ab Perex respiratory system stimulation upon tachycardia detection
EP0838233A1 (en) * 1996-10-18 1998-04-29 Pacesetter AB A tachycardia eliminating apparatus, stimulating the respiratory system
US9042952B2 (en) 1997-01-27 2015-05-26 Lawrence A. Lynn System and method for automatic detection of a plurality of SPO2 time series pattern types
US9468378B2 (en) 1997-01-27 2016-10-18 Lawrence A. Lynn Airway instability detection system and method
US5895416A (en) * 1997-03-12 1999-04-20 Medtronic, Inc. Method and apparatus for controlling and steering an electric field
US9521971B2 (en) 1997-07-14 2016-12-20 Lawrence A. Lynn System and method for automatic detection of a plurality of SPO2 time series pattern types
US6360740B1 (en) 1998-10-14 2002-03-26 Siemens Elema Ab Method and apparatus for assisted breathing
WO2002004066A1 (en) * 2000-07-12 2002-01-17 Wada, Hiromi Body-buried electrode
US10058269B2 (en) 2000-07-28 2018-08-28 Lawrence A. Lynn Monitoring system for identifying an end-exhalation carbon dioxide value of enhanced clinical utility
US8932227B2 (en) 2000-07-28 2015-01-13 Lawrence A. Lynn System and method for CO2 and oximetry integration
US10297348B2 (en) 2001-05-17 2019-05-21 Lawrence A. Lynn Patient safety processor
US10032526B2 (en) 2001-05-17 2018-07-24 Lawrence A. Lynn Patient safety processor
US10354753B2 (en) 2001-05-17 2019-07-16 Lawrence A. Lynn Medical failure pattern search engine
US10366790B2 (en) 2001-05-17 2019-07-30 Lawrence A. Lynn Patient safety processor
US11439321B2 (en) 2001-05-17 2022-09-13 Lawrence A. Lynn Monitoring system for identifying an end-exhalation carbon dioxide value of enhanced clinical utility
US8862196B2 (en) 2001-05-17 2014-10-14 Lawrence A. Lynn System and method for automatic detection of a plurality of SP02 time series pattern types
US9053222B2 (en) 2002-05-17 2015-06-09 Lawrence A. Lynn Patient safety processor
US8706236B2 (en) 2003-07-23 2014-04-22 Synapse Biomedical, Inc. System and method for conditioning a diaphragm of a patient
US8406885B2 (en) 2003-07-23 2013-03-26 Synapse Biomedical, Inc. System and method for conditioning a diaphragm of a patient
US9370657B2 (en) 2003-10-15 2016-06-21 Rmx, Llc Device for manipulating tidal volume and breathing entrainment
US9259573B2 (en) 2003-10-15 2016-02-16 Rmx, Llc Device and method for manipulating exhalation
US7962215B2 (en) 2004-07-23 2011-06-14 Synapse Biomedical, Inc. Ventilatory assist system and methods to improve respiratory function
US7672729B2 (en) 2004-09-10 2010-03-02 Pacesetter, Inc. Multi-variable feedback control of stimulation for inspiratory facilitation
EP1940504A4 (en) * 2005-05-13 2009-02-18 Neurosignal Technologies Inc Method and system to control respiration by means of simulated neuro-electrical coded signals
EP1940504A1 (en) * 2005-05-13 2008-07-09 Neurosignal Technologies, Inc Method and system to control respiration by means of simulated neuro-electrical coded signals
US9050005B2 (en) 2005-08-25 2015-06-09 Synapse Biomedical, Inc. Method and apparatus for transgastric neurostimulation
US8676323B2 (en) 2006-03-09 2014-03-18 Synapse Biomedical, Inc. Ventilatory assist system and methods to improve respiratory function
US9079016B2 (en) 2007-02-05 2015-07-14 Synapse Biomedical, Inc. Removable intramuscular electrode
US9820671B2 (en) 2007-05-17 2017-11-21 Synapse Biomedical, Inc. Devices and methods for assessing motor point electromyogram as a biomarker
US8478412B2 (en) 2007-10-30 2013-07-02 Synapse Biomedical, Inc. Method of improving sleep disordered breathing
US8428726B2 (en) 2007-10-30 2013-04-23 Synapse Biomedical, Inc. Device and method of neuromodulation to effect a functionally restorative adaption of the neuromuscular system
US9138580B2 (en) 2007-10-30 2015-09-22 Synapse Biomedical, Inc. Device and method of neuromodulation to effect a functionally restorative adaption of the neuromuscular system
US8596270B2 (en) 2009-08-20 2013-12-03 Covidien Lp Systems and methods for controlling a ventilator
US11883659B2 (en) * 2009-09-10 2024-01-30 Zoll Respicardia, Inc. Systems for treating disordered breathing by comparing stimulated and unstimulated breathing
US20220111202A1 (en) * 2009-09-10 2022-04-14 Zoll Respicardia, Inc. Respiratory Rectification
US10857363B2 (en) 2014-08-26 2020-12-08 Rmx, Llc Devices and methods for reducing intrathoracic pressure
US11497915B2 (en) 2014-08-26 2022-11-15 Rmx, Llc Devices and methods for reducing intrathoracic pressure
US11471683B2 (en) 2019-01-29 2022-10-18 Synapse Biomedical, Inc. Systems and methods for treating sleep apnea using neuromodulation
US11266838B1 (en) 2019-06-21 2022-03-08 Rmx, Llc Airway diagnostics utilizing phrenic nerve stimulation device and method

Also Published As

Publication number Publication date
EP0190195A4 (en) 1987-09-30
JPS61502518A (en) 1986-11-06
EP0190195A1 (en) 1986-08-13
JPH064098B2 (en) 1994-01-19
FR2566276A1 (en) 1985-12-27
DE3581284D1 (en) 1991-02-14
EP0190195B1 (en) 1991-01-09
FR2566276B1 (en) 1988-07-08

Similar Documents

Publication Publication Date Title
EP0190195B1 (en) Process and apparatus for diaphragmic stimulation
US11400287B2 (en) Obstructive sleep apnea treatment devices, systems and methods
US20230001192A1 (en) Systems And Methods Of Detecting And Treating Obstructive Sleep Apnea
US11951312B2 (en) Method and apparatus for stimulation
US4735205A (en) Method and apparatus including a sliding insulation lead for cardiac assistance
US6269269B1 (en) Method and apparatus for synchronized treatment of obstructive sleep apnea
US9031654B2 (en) Method of stimulating a hypoglossal nerve for controlling the position of a patient&#39;s tongue
US6251126B1 (en) Method and apparatus for synchronized treatment of obstructive sleep apnea
US20030195571A1 (en) Method and apparatus for the treatment of central sleep apnea using biventricular pacing
Creasey et al. Electrical stimulation to restore respiration
US20040030362A1 (en) Method and device for electronically controlling the beating of a heart
US20230172479A1 (en) Single or multiple nerve stimulation to treat sleep disordered breathing
AU2014253460B2 (en) Method of stimulating a hypoglossal nerve for controlling the position of a patient&#39;s tongue
WO2023282922A1 (en) Electrode leads having multi-application helical nerve cuffs and associated systems and methods

Legal Events

Date Code Title Description
AK Designated states

Designated state(s): JP US

AL Designated countries for regional patents

Designated state(s): DE GB IT NL

WWE Wipo information: entry into national phase

Ref document number: 1985903508

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1985903508

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1985903508

Country of ref document: EP